← Back to headlines
Viridian Therapeutics, uniQure N.V. Report Strong Stock Growth
Viridian Therapeutics and uniQure N.V. have both reported substantial year-on-year stock growth, with Viridian posting double-digit gains and uniQure N.V. achieving 30% growth. These figures highlight strong performance for the respective companies.
22 Apr, 14:17 — 22 Apr, 14:17
Sources
Showing 1 of 1 sources
